Balance of two enzymes linked to pancreatic cancer survival

(University of California - San Diego) UC San Diego School of Medicine research sets the stage for clinicians to potentially one day use levels of a pancreatic cancer patient's PHLPP1 and PKC enzymes as a prognostic, and for researchers to develop new therapeutic drugs that inhibit PHLPP1 and boost PKC as a means to treat the disease.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news